Pleural Dynamics, Inc. today announced positive results from a prospective, multicenter study evaluating its Automatic Continuous Effusion Shunt (ACES) device for the management of symptomatic ...
The new data, published this week in JAMA Network Open, show that after adjusting for multiple variables, COVID-19 patients treated with ACE inhibitors and ARBs had a significantly lower risk of death ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback